Key result
A heterozygous ACTC1 mutation caused a combined phenotype of atrial septal defect and late-onset dilated cardiomyopathy, present in 15 affected and absent in 63 healthy family members.
Why the study?
Familial atrial septal defect has been attributed primarily to mutations in cardiac transcription factors, prompting characterization of a novel ACTC1 mutation in a family with ASD and late-onset dilated cardiomyopathy.
Does a mutation in the ACTC1 gene cause familial atrial septal defect associated with late-onset dilated cardiomyopathy?
Observational (n=78)
Does a mutation in the ACTC1 gene cause familial atrial septal defect associated with late-onset dilated cardiomyopathy?
A novel ACTC1 mutation (p.Gly247Asp) causes a combined phenotype of familial atrial septal defect and late-onset dilated cardiomyopathy through defective actin polymerization, suggesting patients with ASD and this mutation should be monitored for heart failure.
Answers are grounded in this paper and cite their sources.
May support ACTC1 testing and HF surveillance in familial ASD-DCM; extends phenotypes but leaves validation open.
BACKGROUND: Familial atrial septal defect (ASD) has previously been attributed primarily to mutations in cardiac transcription factors. Here, we report a large, multi-generational family (78 members) with ASD combined with a late-onset dilated cardiomyopathy and further characterize the consequences of mutant α-actin. METHODS: We combined a genome-wide linkage analysis with cell biology, microscopy, and molecular biology tools to characterize a novel ACTC1 (cardiac α-actin) mutation identified in association with ASD and late-onset dilated cardiomyopathy in a large, multi-generational family. RESULTS: Using a genome-wide linkage analysis, the ASD disease locus was mapped to chromosome 15q14 harboring the ACTC1 gene. In 15 affected family members, a heterozygous, nonsynonymous, and fully penetrant mutation (p. Gly247Asp) was identified in exon 5 of ACTC1 that was absent in all healthy family members (n=63). In silico tools predicted deleterious consequences of this variant that was found absent in control databases. Ultrastructural analysis of myocardial tissue of one of the mutation carriers showed sarcomeric disarray, myofibrillar degeneration, and increased apoptosis, while cardiac proteomics revealed a significant increase in extracellular matrix proteins. Consistently, structural defects and increased apoptosis were also observed in neonatal rat ventricular cardiomyocytes overexpressing the mutant, but not native human ACTC1. Molecular dynamics studies and additional mechanistic analyses in cardiomyocytes confirmed actin polymerization/turnover defects, thereby affecting contractility. CONCLUSIONS: A combined phenotype of ASD and late-onset heart failure was caused by a heterozygous, nonsynonymous ACTC1 mutation. Mechanistically, we found a shared molecular mechanism of defective actin signaling and polymerization in both cardiac development and contractile function. Detection of ACTC1 mutations in patients with ASD may thus have further clinical implications with regard to monitoring for (late-onset) dilated cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Frank et al. (2019) conducted an observational in Atrial septal defect and late-onset dilated cardiomyopathy (n=78). ACTC1 (p. Gly247Asp) mutation vs. Absence of ACTC1 mutation was evaluated on Atrial septal defect and late-onset dilated cardiomyopathy. A heterozygous ACTC1 mutation caused a combined phenotype of atrial septal defect and late-onset dilated cardiomyopathy, present in 15 affected and absent in 63 healthy family members.
Synapse has enriched 10 related papers. Consider them for comparative context: